{"id":"https://openalex.org/W3105840183","doi":null,"title":"Updated Results of Phase 1b Study of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate with Extended Durability, in wAMD, DME, and RVO","display_name":"Updated Results of Phase 1b Study of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate with Extended Durability, in wAMD, DME, and RVO","publication_year":2020,"publication_date":"2020-06-10","ids":{"openalex":"https://openalex.org/W3105840183","mag":"3105840183"},"language":"en","primary_location":{"id":"mag:3105840183","doi":null,"is_oa":true,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2769586","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://iovs.arvojournals.org/article.aspx?articleid=2769586","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044390932","display_name":"Sunil S. Patel","orcid":"https://orcid.org/0000-0002-0511-4942","observed_orcids":["https://orcid.org/0000-0002-0511-4942"]},"institutions":[{"id":"https://openalex.org/I4210123700","display_name":"Retina Research Institute of Texas","ror":"https://ror.org/0260mkc43","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210123700"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sunil Patel","raw_affiliation_strings":["Retina Research Institute of Texas, Abilene, Texas, United States"],"raw_orcid":"https://orcid.org/0000-0002-0511-4942","affiliations":[{"raw_affiliation_string":"Retina Research Institute of Texas, Abilene, Texas, United States","institution_ids":["https://openalex.org/I4210123700"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082943801","display_name":"Daniel Janer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Janer","raw_affiliation_strings":["Kodiak Sciences, Palo Alto, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kodiak Sciences, Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080198895","display_name":"Bryce Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bryce Miller","raw_affiliation_strings":["Kodiak Sciences, Palo Alto, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kodiak Sciences, Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004182595","display_name":"Jason S. Ehrlich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason S. Ehrlich","raw_affiliation_strings":["Kodiak Sciences, Palo Alto, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kodiak Sciences, Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004704887","display_name":"Victor Perlroth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor Perlroth","raw_affiliation_strings":["Kodiak Sciences, Palo Alto, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kodiak Sciences, Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052024887","display_name":"J. Pablo Velazquez-Martin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Pablo Velazquez-Martin","raw_affiliation_strings":["Kodiak Sciences, Palo Alto, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kodiak Sciences, Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1850,"currency":"USD","value_usd":1850},"apc_paid":{"value":1850,"currency":"USD","value_usd":1850},"fwci":2.3952,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.88896626,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"61","issue":"7","first_page":"4286","last_page":"4286"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-vegf-antibody","display_name":"anti-VEGF antibody","score":0.9520000219345093},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9459999799728394},{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":0.9980000257492065},{"id":"https://openalex.org/keywords/retinal-vein-occlusion","display_name":"retinal vein occlusion","score":0.9679999947547913}],"concepts":[{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.7226698398590088},{"id":"https://openalex.org/C104304963","wikidata":"https://www.wikidata.org/wiki/Q5316114","display_name":"Durability","level":2,"score":0.6779108047485352},{"id":"https://openalex.org/C2778636629","wikidata":"https://www.wikidata.org/wiki/Q422649","display_name":"Biopolymer","level":3,"score":0.6635007262229919},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.5210051536560059},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.4584578573703766},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38432615995407104},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.305674284696579},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27427297830581665},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.19689616560935974},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1919631063938141},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.12148803472518921},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.07561138272285461},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.02858799695968628},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3105840183","doi":null,"is_oa":true,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2769586","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null}],"best_oa_location":{"id":"mag:3105840183","doi":null,"is_oa":true,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2769586","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2908753689","https://openalex.org/W4250804654","https://openalex.org/W3181931777","https://openalex.org/W4221070624","https://openalex.org/W4250254045","https://openalex.org/W3098257960","https://openalex.org/W880722523","https://openalex.org/W2994540577","https://openalex.org/W3186140591","https://openalex.org/W1003415126"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2020-11-23T00:00:00"}